Xth Eurasian Hematology-Oncology Congress

http://www.ehog.net/

 

2019 SOHO Updates on CML: Frontline Therapy is Good, Getting Better and Safer, 2nd Line Options Grossly Equivalent, 3rd Line Ponatinib is Better, Complete Cytogenetic Response Improves Survival

152 views
December 13, 2019
Comments 0
Login to view comments. Click here to Login